Stock Events

Stock Events

Kalvista Pharmaceuticals (KALV) Q1 2026 Earnings

14MayConfirmed

Q3 2025

Q3 2025

Q4 2025

Q1 2026

-1.12

-0.87

-0.63

-0.38

Details

Expected EPS

-0.38

Actual EPS

-0.43

Surprise EPS

-0.05

Surprise Percent

+13.16%

Description

Kalvista Pharmaceuticals (KALV) has reported earnings of -0.43 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.